新的基因疗法显示了扭转猪心脏衰竭的希望,计划进行人类试验。 New gene therapy shows promise in reversing heart failure in pigs, with human trials planned.

新的基因疗法在通过使用无害病毒提供关键心脏病蛋白(cBIN1), 扭转猪的心脏衰竭方面, 已经显示出令人乐观的成果。 A new gene therapy has shown promising results in reversing heart failure in pigs by delivering a critical heart protein, cBIN1, using a harmless virus. 这一疗法大大提高了心脏功能和效率,研究人员计划使其适应人类试验,争取在2025年秋季前获得林业发展局的批准。 This therapy significantly improved heart function and efficiency, and researchers plan to adapt it for human trials, aiming for FDA approval by fall 2025. 如果人体测试成功,这种治疗可以为心脏衰竭病人提供一个变革性选择。 The treatment could offer a transformative option for heart failure patients if successful in human testing.